The independent platform for news, articles and advice for professionals in laboratory medicine

Enalees appoints Eric Germain as managing director

Enalees, a biotech company producing rapid molecular diagnostic tests for the veterinary profession based on an isothermal amplification technique (LAMP PCR), today announces that it has appointed Eric Germain to the position of managing director.

In his new role, Eric will provide support for company president and co-founder, Laurent Thiery, as the group continues on its path of growth and global expansion.

Eric Germain has more than 25 years’ experience in strategic and decision-making roles, which include being responsible for territorial expansion and economic development. After completing a master’s degree in biology at the Université d’Orsay in Paris, France, and spending his early career in the education sector, Eric Germain went on to various roles as managing director and chief of staff within both private groups and French public institutions including Genopole. In previous roles he has also promoted the creation of innovative businesses in the fields of genomics and the environment in the Paris area.

“We’re delighted to welcome Eric Germain to Enalees. He is exactly the kind of person that I want to have beside me. He joins us at a key strategic moment for Enalees, as we look to build our European and global operations, while continuing our search for funds to meet the market needs and our growth ambitions," said Laurent Thiery, president and co-founder of Enalees.

In 2022, Enalees opened its first European branch, in the UK, marking the first strategic step on its roadmap to establishing a European group specialized in rapid molecular diagnostic tests for the veterinary profession. Thanks to a €500,000 ($537K) subsidy from the Île-de-France region (France), the group also expanded its R&D team and took steps to strengthen its supply and production chains.

In 2023, Enalees plans to open a series of new branches in Europe and set up a new proteomic development and manufacturing facility at its Genopole site. Between now and 2024 the company will also continue to expand its sales team.

 

Upcoming Events

POCT: The Power to Disrupt

The Jubilee Hotel and Conferences, Nottingham
28 March 2023

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

POCT: The Power to Disrupt

The Jubilee Hotel and Conferences, Nottingham
28 March 2023

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

Annual SHOT Symposium 2023

Etihad Stadium, Manchester, M11 3FF
4 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2023 Step Communications Ltd. Registered in England. Registration Number 3893025